NRG Therapeutics to develop small molecule disease-modifying medicines for debilitating chronic neurodegenerative disorders

Drug Target Review

£2.68M Award to NRG Therapeutics Supports Work Into Potential DMTNRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner...